Monitoring Periodic blood tests (e.g., serum B12 levels, complete blood counts) may be recommended to ensure the therapy is effective and safe
Funding No external funding was received
Healthcare providers currently prescribe anti-obesity medications off-label for SUD-related indications, while clinical trials are ongoing
[Google Scholar] 35.Mannucci E., Ognibene A., Cremasco F., Bardini G., Mencucci A., Pierazzuoli E., Ciani S., Messeri G., Rotella C.M
Indications and Usage Saxenda (liraglutide) injection 3 mg is indicated in combination with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with body weight greater than 60kg and obesity Adults with overweight in the presence of at least one weight related comorbid condition Limitations of Use Saxenda contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist The safety and effectiveness of Saxenda in pediatric patients with type 2 diabetes have not been established References 1
By aiming for 1.21.6g of protein per kg of body weight , and spreading that across 3040g per meal , youll help: Preserve lean muscle Maintain steady energy Stay full between meals Optimise your fat loss Think of it this way: Youre not just losing weight youre building strength and long-term health